Logo image of INLX

INTELLINETICS INC (INLX) Stock Fundamental Analysis

USA - NYSEARCA:INLX - US45825X2045 - Common Stock

11.08 USD
-0.02 (-0.18%)
Last: 10/20/2025, 8:04:01 PM
Fundamental Rating

3

INLX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. The financial health of INLX is average, but there are quite some concerns on its profitability. INLX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year INLX has reported negative net income.
In the past year INLX had a positive cash flow from operations.
In multiple years INLX reported negative net income over the last 5 years.
In the past 5 years INLX always reported a positive cash flow from operatings.
INLX Yearly Net Income VS EBIT VS OCF VS FCFINLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

INLX's Return On Assets of -10.15% is on the low side compared to the rest of the industry. INLX is outperformed by 61.40% of its industry peers.
With a Return On Equity value of -15.06%, INLX perfoms like the industry average, outperforming 44.91% of the companies in the same industry.
Industry RankSector Rank
ROA -10.15%
ROE -15.06%
ROIC N/A
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
INLX Yearly ROA, ROE, ROICINLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

The Gross Margin of INLX (65.50%) is comparable to the rest of the industry.
INLX's Gross Margin has declined in the last couple of years.
INLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
INLX Yearly Profit, Operating, Gross MarginsINLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

INLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INLX has been increased compared to 1 year ago.
Compared to 5 years ago, INLX has more shares outstanding
The debt/assets ratio for INLX has been reduced compared to a year ago.
INLX Yearly Shares OutstandingINLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
INLX Yearly Total Debt VS Total AssetsINLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

INLX has an Altman-Z score of 4.16. This indicates that INLX is financially healthy and has little risk of bankruptcy at the moment.
INLX's Altman-Z score of 4.16 is fine compared to the rest of the industry. INLX outperforms 66.32% of its industry peers.
The Debt to FCF ratio of INLX is 0.16, which is an excellent value as it means it would take INLX, only 0.16 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.16, INLX belongs to the best of the industry, outperforming 81.05% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that INLX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, INLX is in the better half of the industry, outperforming 63.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.16
Altman-Z 4.16
ROIC/WACCN/A
WACC11.15%
INLX Yearly LT Debt VS Equity VS FCFINLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

INLX has a Current Ratio of 0.98. This is a bad value and indicates that INLX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.98, INLX is doing worse than 73.68% of the companies in the same industry.
A Quick Ratio of 0.95 indicates that INLX may have some problems paying its short term obligations.
The Quick ratio of INLX (0.95) is worse than 72.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.95
INLX Yearly Current Assets VS Current LiabilitesINLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

INLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1100.00%.
The Revenue has decreased by -2.63% in the past year.
Measured over the past years, INLX shows a very strong growth in Revenue. The Revenue has been growing by 48.02% on average per year.
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-13.59%

3.2 Future

INLX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -54.27% yearly.
INLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.13% yearly.
EPS Next Y-325%
EPS Next 2Y-54.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.04%
Revenue Next 2Y4.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INLX Yearly Revenue VS EstimatesINLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
INLX Yearly EPS VS EstimatesINLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

INLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INLX Price Earnings VS Forward Price EarningsINLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, INLX is valued a bit cheaper than 67.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.74
EV/EBITDA N/A
INLX Per share dataINLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as INLX's earnings are expected to decrease with -54.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLINETICS INC

NYSEARCA:INLX (10/20/2025, 8:04:01 PM)

11.08

-0.02 (-0.18%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners7.51%
Inst Owner Change0%
Ins Owners27.64%
Ins Owner Change0.43%
Market Cap49.64M
Revenue(TTM)17.13M
Net Income(TTM)-1741700
Analysts82.86
Price Target14.79 (33.48%)
Short Float %0.02%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-32.42%
Min EPS beat(2)-85.19%
Max EPS beat(2)20.34%
EPS beat(4)2
Avg EPS beat(4)-239.86%
Min EPS beat(4)-982.35%
Max EPS beat(4)87.75%
EPS beat(8)3
Avg EPS beat(8)-157.68%
EPS beat(12)6
Avg EPS beat(12)-29.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.01%
Min Revenue beat(2)-7.48%
Max Revenue beat(2)-6.54%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-7.48%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-2.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)8
Avg Revenue beat(16)0.13%
PT rev (1m)0%
PT rev (3m)-12.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-31.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.9
P/FCF 36.74
P/OCF 22.04
P/B 4.29
P/tB 25.33
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)0.3
FCFY2.72%
OCF(TTM)0.5
OCFY4.54%
SpS3.82
BVpS2.58
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.15%
ROE -15.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.5%
FCFM 7.89%
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
F-Score5
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.16
Debt/EBITDA N/A
Cap/Depr 68.63%
Cap/Sales 5.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.95
Altman-Z 4.16
F-Score5
WACC11.15%
ROIC/WACCN/A
Cap/Depr(3y)67.37%
Cap/Depr(5y)74.13%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
EPS Next Y-325%
EPS Next 2Y-54.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.63%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-13.59%
Revenue Next Year-5.04%
Revenue Next 2Y4.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-326.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.78%
FCF growth 3Y55.92%
FCF growth 5YN/A
OCF growth 1Y39.3%
OCF growth 3Y40.54%
OCF growth 5YN/A